Estrogens, antiestrogens and cell proliferation
- 1 June 1989
- Vol. 10 (6) , 210-214
- https://doi.org/10.1002/bies.950100608
Abstract
The classical estrogen receptor model does not sufficiently account for the tumor‐promoting activity of extrogens or for the antiproliferative effect of antiestrogens in estrogen‐dependent tumors. Particular difficulties not readily accommodated within the model are that hormonal autonomy can supervene without loss of the estrogen receptor and that antiestrogen effects are highly context‐dependent, without apparent differences in the estrogen receptor itself or in metabolic transformation of antiestrogens. Recent studies suggest that estrogens may promote cell proliferation, in part, through the mediation of growth factors and that antiestrogens may exert some of their effects by mechanisms unrelated to the estrogen receptor.Keywords
This publication has 22 references indexed in Scilit:
- The human oestrogen receptor functions in yeastNature, 1988
- Modulation of C-myc by transforming growth factor-β in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1988
- Transforming Growth Factor-β2: cDNA Cloning and Sequence AnalysisDNA, 1988
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987
- Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor β in a human breast carcinoma cell lineBiochemical and Biophysical Research Communications, 1987
- Transforming Growth Factor-β: Biological Function and Chemical StructureScience, 1986
- Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal developmentCell, 1986
- Tumor Necrosis Factors: Gene Structure and Biological ActivitiesPublished by Cold Spring Harbor Laboratory ,1986
- Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivoBiochemical Pharmacology, 1985
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984